Developer docs
API playgroundTry for free, no card

Search company profiles

PoongLim Pharmatech

Full company profile

uuid002iyhh

Namestring
PoongLim Pharmatech
Legal namestring
(주)풍림파마텍
Websiteurl
plpt.co.kr
Company typeenum
Private
Founded yearint
1999
Descriptiontext

PoongLim Pharmatech (풍림파마텍) is a South Korea-based medical device manufacturer founded in 1999 and headquartered in the Gunsan Free Trade Zone, Jeollabuk-do. The company designs, manufactures, and supplies syringes, sterile needles, pre-fillable glass barrels, and related medical devices — including its flagship LDV (Low Dead Volume) syringe, which minimizes residual liquid to enable 6+ vaccine doses per vial versus 5 with standard syringes. Its operations are certified under MFDS GMP, ISO 13485, FDA approval, CE marking, ISO 11135, ISO 10993, and DMF Type III standards, allowing export to the US, Japan, India, Saudi Arabia, Mexico, and other markets. The product portfolio spans core PFS/syringe/needle lines plus bone cement, cosmetic, dental, veterinary, blood processing, fat separation, and ophthalmic needle products.

The company's business model combines B2B hardware sales to pharmaceutical manufacturers, hospital procurement channels, and government health agencies with an exclusive domestic distribution franchise for SCHOTT AG's PFS products in Korea (in place since 2002 and restructured post-2025 to a virtually unlimited term). Revenue is generated through direct enterprise sales, export contracts, government procurement, and licensing/distribution margins. FY2024 sales were 93.2 billion KRW with operating profit of 5.4 billion KRW (~5.8% margin); export milestones include a $7M export tower in 2021 and a $50M export contract signed at the World Korean Business Conference. The company employs 251–500 people across its Gunsan headquarters and Saemangeum production complex (Factory 3 operational with 20M units/month LDV capacity; Factory 4 under construction for ophthalmic/joint and diagnostic devices).

In November 2025, bnw Investment and Elio PE acquired approximately 88% of PoongLim Pharmatech for about 1,000 billion KRW, taking the company private; the Cho founding family retained ~12%, with second-generation owner Jo Mi-hee continuing as representative director to manage client relationships and ongoing international expansion including the 2023 Allcare Group joint venture for a Saudi Arabia manufacturing facility.

Short descriptiontext

PoongLim Pharmatech is a South Korean medical device manufacturer specializing in pre-filled syringes, LDV vaccine syringes, sterile needles, and glass barrel components. The company serves pharmaceutical manufacturers, hospitals, and government health agencies domestically and across the US, Japan, India, and the Middle East.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersGunsan, South Korea
HQ citystring
Gunsan
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device manufacturing, pre-filled syringes, sterile needles, pharmaceutical packaging, LDV syringes
Product category
Medical Device Manufacturing
No data
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Device Manufacturing and Sales
TypeHardware Sales
Description

Designs, manufactures, and sells syringes, needles, vials, and related medical devices to pharmaceutical companies, hospitals, and government health agencies. Products include LDV syringes, pre-fillable glass barrels, sterile needles, catheter/cannulas, bone cement syringes, dental syringes, cosmetic syringes, veterinary syringes, blood processing equipment, fat separation equipment, blood collection devices, and polydioxanone sutures. Revenue is generated through direct B2B sales, export contracts, and government procurement.

plpt.co.kr
2International Distribution Rights (SCHOTT)
TypeLicensing Royalties
Description

As the exclusive domestic distributor of SCHOTT's PFS products in Korea, the company earns revenue through importing and distributing SCHOTT glass barrels, vials, and cylinders. The long-term distribution agreement was restructured post-acquisition with virtually unlimited duration.

plpt.co.kr
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Pricing details1 tier
1B2B enterprise pricing — direct sales to pharmaceutical companies, hospitals, and government agencies.
ModelOtherBilling cadenceMulti-year contract
Notes

No public pricing available. Quote-based B2B model. Contact via company customer inquiry form or direct sales team.

plpt.co.kr
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

No source material was provided in the input to describe the company's core offering.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • LDV syringe yields 6+ vaccine doses per vial vs. 5 doses with standard syringes, increasing vaccination efficiency by 20%+
+5 more records
Product overview1 text field

PoongLim Pharmatech (풍림파마텍) is a medical device manufacturer specializing in prefillable syringes, syringes, needles, and medical accessories. The company operates as a single unified product portfolio rather than a platform-plus-modules architecture. Core products include the LDV (Low Dead Volume) Sterile Syringe and Kopac HL Prefillable Glass Barrel as the flagship offerings, complemented by the EZ-Injec sterile needle line (including LDV variants), bone cement syringes, cosmetic syringes, dental syringes, and animal/livestock syringes. The product range also includes blood processing equipment, fat separation equipment, blood collection/transfusion equipment, PDO sutures, prefilled syringe accessories (plunger rods, finger grips), universal catheter cannulas, ophthalmic needles, and sterile needles. The company gained global recognition during the COVID-19 pandemic with its LDV syringe technology that minimizes vaccine waste, enabling more doses per vial.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global medical device incumbent with leading positions in syringes, needles, and drug delivery systems serving pharmaceutical manufacturers and hospitals. BD is a broader incumbent whose product portfolio overlaps with PoongLim's LDV syringes, sterile needles, and pre-fillable systems.

TypeDirect peer
Description

Italian-headquartered provider of drug containment, drug delivery, and diagnostic solutions including glass pre-filled syringes. Directly comparable in PFS systems and contract manufacturing for pharmaceutical customers globally.

TypeDirect peer
Description

Specialty provider of drug delivery and active material science solutions including pre-filled syringe components. Aptar is explicitly listed as a global partner on PoongLim's website and competes in the same PFS drug delivery category.

TypeDirect peer
Description

Global leader in primary packaging for pharmaceuticals including pre-filled glass syringes. SCHOTT is both PoongLim's core supplier and a direct competitor in PFS systems, making it the closest comparable in product, technology, and customer base.

TypeDirect peer
Description

Global leader in drug containment and delivery including pre-filled syringe components, elastomeric closures, and injection systems. Directly comparable in PFS and injectable drug delivery technology for pharmaceutical manufacturers.

6Terumo
TypeDirect peer
Description

Japanese medical device manufacturer with a strong PFS and injection systems portfolio serving pharmaceutical companies and hospitals. Directly comparable in pre-filled syringes, needles, and sterile medical devices, and a relevant Asian peer.

TypeBroad incumbent
Description

Global medical device and pharmaceutical solutions company with a broad portfolio including syringes, infusion systems, and sterile needles. A broader incumbent whose product overlap with PoongLim's syringes and injection devices creates direct competitive overlap in some segments.

TypeEmerging player
Description

Swiss specialist in injection and infusion systems including pre-filled syringes and pen injectors. Comparable as a focused player in injectable drug delivery, though more oriented toward self-injection devices than commodity PFS.

TypeDirect peer
Description

European specialty manufacturer of glass and plastic primary packaging for pharma, including pre-fillable syringes. Directly comparable in PFS and injectable device offerings serving global pharmaceutical customers.

10Nipro
TypeDirect peer
Description

Japanese medical device manufacturer producing syringes, needles, and pharmaceutical packaging. Directly comparable in disposable syringes and PFS-related products, with similar geographic focus across Asia and emerging markets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PoongLim Pharmatech

Medical Device Manufacturingplpt.co.kr

PoongLim Pharmatech is a South Korean medical device manufacturer specializing in pre-filled syringes, LDV vaccine syringes, sterile needles, and glass barrel components. The company serves pharmaceutical manufacturers, hospitals, and government health agencies domestically and across the US, Japan, India, and the Middle East.

What PoongLim Pharmatech does

PoongLim Pharmatech (풍림파마텍) is a South Korea-based medical device manufacturer founded in 1999 and headquartered in the Gunsan Free Trade Zone, Jeollabuk-do. The company designs, manufactures, and supplies syringes, sterile needles, pre-fillable glass barrels, and related medical devices — including its flagship LDV (Low Dead Volume) syringe, which minimizes residual liquid to enable 6+ vaccine doses per vial versus 5 with standard syringes. Its operations are certified under MFDS GMP, ISO 13485, FDA approval, CE marking, ISO 11135, ISO 10993, and DMF Type III standards, allowing export to the US, Japan, India, Saudi Arabia, Mexico, and other markets. The product portfolio spans core PFS/syringe/needle lines plus bone cement, cosmetic, dental, veterinary, blood processing, fat separation, and ophthalmic needle products.

The company's business model combines B2B hardware sales to pharmaceutical manufacturers, hospital procurement channels, and government health agencies with an exclusive domestic distribution franchise for SCHOTT AG's PFS products in Korea (in place since 2002 and restructured post-2025 to a virtually unlimited term). Revenue is generated through direct enterprise sales, export contracts, government procurement, and licensing/distribution margins. FY2024 sales were 93.2 billion KRW with operating profit of 5.4 billion KRW (~5.8% margin); export milestones include a $7M export tower in 2021 and a $50M export contract signed at the World Korean Business Conference. The company employs 251–500 people across its Gunsan headquarters and Saemangeum production complex (Factory 3 operational with 20M units/month LDV capacity; Factory 4 under construction for ophthalmic/joint and diagnostic devices).

In November 2025, bnw Investment and Elio PE acquired approximately 88% of PoongLim Pharmatech for about 1,000 billion KRW, taking the company private; the Cho founding family retained ~12%, with second-generation owner Jo Mi-hee continuing as representative director to manage client relationships and ongoing international expansion including the 2023 Allcare Group joint venture for a Saudi Arabia manufacturing facility.

PoongLim Pharmatech firmographics

Firmographics
Name
PoongLim Pharmatech
Legal name
(주)풍림파마텍
Website
https://plpt.co.kr
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
251–500 employees
Short description
PoongLim Pharmatech is a South Korean medical device manufacturer specializing in pre-filled syringes, LDV vaccine syringes, sterile needles, and glass barrel components. The company serves pharmaceutical manufacturers, hospitals, and government health agencies domestically and across the US, Japan, India, and the Middle East.
Ownership category
akta.pro rank

Where PoongLim Pharmatech is headquartered

Location

Headquarters

HQ city
Gunsan
HQ country
South Korea
HQ region
Asia

Offices3 records

Markets served

PoongLim Pharmatech business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing

Revenue model

  1. Medical Device Manufacturing and Sales: Designs, manufactures, and sells syringes, needles, vials, and related medical devices to pharmaceutical companies, hospitals, and government health agencies. Products include LDV syringes, pre-fillable glass barrels, sterile needles, catheter/cannulas, bone cement syringes, dental syringes, cosmetic syringes, veterinary syringes, blood processing equipment, fat separation equipment, blood collection devices, and polydioxanone sutures. Revenue is generated through direct B2B sales, export contracts, and government procurement.
  2. International Distribution Rights (SCHOTT): As the exclusive domestic distributor of SCHOTT's PFS products in Korea, the company earns revenue through importing and distributing SCHOTT glass barrels, vials, and cylinders. The long-term distribution agreement was restructured post-acquisition with virtually unlimited duration.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractB2B enterprise pricing — direct sales to pharmaceutical companies, hospitals, and government agencies.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

PoongLim Pharmatech product offering

Product offering

Core offering

No source material was provided in the input to describe the company's core offering.

Product overview

PoongLim Pharmatech (풍림파마텍) is a medical device manufacturer specializing in prefillable syringes, syringes, needles, and medical accessories. The company operates as a single unified product portfolio rather than a platform-plus-modules architecture. Core products include the LDV (Low Dead Volume) Sterile Syringe and Kopac HL Prefillable Glass Barrel as the flagship offerings, complemented by the EZ-Injec sterile needle line (including LDV variants), bone cement syringes, cosmetic syringes, dental syringes, and animal/livestock syringes. The product range also includes blood processing equipment, fat separation equipment, blood collection/transfusion equipment, PDO sutures, prefilled syringe accessories (plunger rods, finger grips), universal catheter cannulas, ophthalmic needles, and sterile needles. The company gained global recognition during the COVID-19 pandemic with its LDV syringe technology that minimizes vaccine waste, enabling more doses per vial.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • LDV syringe yields 6+ vaccine doses per vial vs. 5 doses with standard syringes, increasing vaccination efficiency by 20%+
  • +5 more outcomes

Companies that use PoongLim Pharmatech

Customer profile

Named customers2 records

Segments3 records

PoongLim Pharmatech technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

PoongLim Pharmatech partnerships and signals

Strategic signal

Scale indicators13 records

Recent moves9 records

Expansion highlights6 records

PoongLim Pharmatech competitors and assessment

Company assessment

Broad incumbents

  • Becton, Dickinson and Company (BD): Global medical device incumbent with leading positions in syringes, needles, and drug delivery systems serving pharmaceutical manufacturers and hospitals. BD is a broader incumbent whose product portfolio overlaps with PoongLim's LDV syringes, sterile needles, and pre-fillable systems.
  • B. Braun: Global medical device and pharmaceutical solutions company with a broad portfolio including syringes, infusion systems, and sterile needles. A broader incumbent whose product overlap with PoongLim's syringes and injection devices creates direct competitive overlap in some segments.

Direct peers

  • Stevanato Group: Italian-headquartered provider of drug containment, drug delivery, and diagnostic solutions including glass pre-filled syringes. Directly comparable in PFS systems and contract manufacturing for pharmaceutical customers globally.
  • Aptar Pharma: Specialty provider of drug delivery and active material science solutions including pre-filled syringe components. Aptar is explicitly listed as a global partner on PoongLim's website and competes in the same PFS drug delivery category.
  • SCHOTT Pharma: Global leader in primary packaging for pharmaceuticals including pre-filled glass syringes. SCHOTT is both PoongLim's core supplier and a direct competitor in PFS systems, making it the closest comparable in product, technology, and customer base.
  • West Pharmaceutical Services: Global leader in drug containment and delivery including pre-filled syringe components, elastomeric closures, and injection systems. Directly comparable in PFS and injectable drug delivery technology for pharmaceutical manufacturers.
  • Terumo: Japanese medical device manufacturer with a strong PFS and injection systems portfolio serving pharmaceutical companies and hospitals. Directly comparable in pre-filled syringes, needles, and sterile medical devices, and a relevant Asian peer.
  • Gerresheimer: European specialty manufacturer of glass and plastic primary packaging for pharma, including pre-fillable syringes. Directly comparable in PFS and injectable device offerings serving global pharmaceutical customers.
  • Nipro: Japanese medical device manufacturer producing syringes, needles, and pharmaceutical packaging. Directly comparable in disposable syringes and PFS-related products, with similar geographic focus across Asia and emerging markets.

Emerging players

  • Ypsomed: Swiss specialist in injection and infusion systems including pre-filled syringes and pen injectors. Comparable as a focused player in injectable drug delivery, though more oriented toward self-injection devices than commodity PFS.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

PoongLim Pharmatech compliance and trust

Trust signal

Compliance8 records

PoongLim Pharmatech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PoongLim Pharmatech leadership team

Management profile

Number of profiles

PoongLim Pharmatech funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PoongLim Pharmatech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PoongLim Pharmatech

What does PoongLim Pharmatech do?

No source material was provided in the input to describe the company's core offering.

Is PoongLim Pharmatech a public or private company?

PoongLim Pharmatech is a private company. It is classified as unknown and is currently operating.

When was PoongLim Pharmatech founded?

PoongLim Pharmatech was founded in 1999. It employs 251 to 500 people.

Where is PoongLim Pharmatech based?

PoongLim Pharmatech is headquartered in Gunsan, South Korea, in the Asia region.

How does PoongLim Pharmatech make money?

Two revenue lines are on record. Medical Device Manufacturing and Sales are the primary driver. The others are international Distribution Rights (SCHOTT).

Who are PoongLim Pharmatech's main competitors?

Broad incumbents on record are Becton, Dickinson and Company (BD) and B. Braun. Direct peers are Stevanato Group, Aptar Pharma, SCHOTT Pharma, West Pharmaceutical Services, Terumo, Gerresheimer and Nipro. Ypsomed is listed as an emerging player.

Does PoongLim Pharmatech have an API?

No public API is recorded for PoongLim Pharmatech.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales